169 related articles for article (PubMed ID: 30143633)
1. Nanomedicines reveal how PBOV1 promotes hepatocellular carcinoma for effective gene therapy.
Guo Y; Wu Z; Shen S; Guo R; Wang J; Wang W; Zhao K; Kuang M; Shuai X
Nat Commun; 2018 Aug; 9(1):3430. PubMed ID: 30143633
[TBL] [Abstract][Full Text] [Related]
2. Theranostical nanosystem-mediated identification of an oncogene and highly effective therapy in hepatocellular carcinoma.
Guo Y; Wang J; Zhang L; Shen S; Guo R; Yang Y; Chen W; Wang Y; Chen G; Shuai X
Hepatology; 2016 Apr; 63(4):1240-55. PubMed ID: 26680504
[TBL] [Abstract][Full Text] [Related]
3. Kindlin-2 promotes hepatocellular carcinoma invasion and metastasis by increasing Wnt/β-catenin signaling.
Lin J; Lin W; Ye Y; Wang L; Chen X; Zang S; Huang A
J Exp Clin Cancer Res; 2017 Sep; 36(1):134. PubMed ID: 28969700
[TBL] [Abstract][Full Text] [Related]
4. Autophagy promotes metastasis and glycolysis by upregulating MCT1 expression and Wnt/β-catenin signaling pathway activation in hepatocellular carcinoma cells.
Fan Q; Yang L; Zhang X; Ma Y; Li Y; Dong L; Zong Z; Hua X; Su D; Li H; Liu J
J Exp Clin Cancer Res; 2018 Jan; 37(1):9. PubMed ID: 29351758
[TBL] [Abstract][Full Text] [Related]
5. miR-122 enhances sensitivity of hepatocellular carcinoma to oxaliplatin via inhibiting MDR1 by targeting Wnt/β-catenin pathway.
Cao F; Yin LX
Exp Mol Pathol; 2019 Feb; 106():34-43. PubMed ID: 30539797
[TBL] [Abstract][Full Text] [Related]
6. Insulin-like Growth Factor I Receptor: A Novel Target for Hepatocellular Carcinoma Gene Therapy.
Wang L; Yao M; Zheng W; Fang M; Wu M; Sun J; Dong Z; Yao D
Mini Rev Med Chem; 2019; 19(4):272-280. PubMed ID: 30360707
[TBL] [Abstract][Full Text] [Related]
7. Role of IQGAP3 in metastasis and epithelial-mesenchymal transition in human hepatocellular carcinoma.
Shi Y; Qin N; Zhou Q; Chen Y; Huang S; Chen B; Shen G; Jia H
J Transl Med; 2017 Aug; 15(1):176. PubMed ID: 28810875
[TBL] [Abstract][Full Text] [Related]
8. beta-catenin siRNA regulation of apoptosis- and angiogenesis-related gene expression in hepatocellular carcinoma cells: potential uses for gene therapy.
Wang XH; Sun X; Meng XW; Lv ZW; Du YJ; Zhu Y; Chen J; Kong DX; Jin SZ
Oncol Rep; 2010 Oct; 24(4):1093-9. PubMed ID: 20811694
[TBL] [Abstract][Full Text] [Related]
9. The long non-coding RNA PTTG3P promotes cell growth and metastasis via up-regulating PTTG1 and activating PI3K/AKT signaling in hepatocellular carcinoma.
Huang JL; Cao SW; Ou QS; Yang B; Zheng SH; Tang J; Chen J; Hu YW; Zheng L; Wang Q
Mol Cancer; 2018 May; 17(1):93. PubMed ID: 29803224
[TBL] [Abstract][Full Text] [Related]
10. Transducin (Beta)-Like 1 X-Linked Receptor 1 Correlates with Clinical Prognosis and Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma.
Kuang X; Zhu J; Peng Z; Wang J; Chen Z
Dig Dis Sci; 2016 Feb; 61(2):489-500. PubMed ID: 26386862
[TBL] [Abstract][Full Text] [Related]
11. Let-7 inhibits self-renewal of hepatocellular cancer stem-like cells through regulating the epithelial-mesenchymal transition and the Wnt signaling pathway.
Jin B; Wang W; Meng XX; Du G; Li J; Zhang SZ; Zhou BH; Fu ZH
BMC Cancer; 2016 Nov; 16(1):863. PubMed ID: 27821157
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-27a-3p inhibits cell viability and migration through down-regulating DUSP16 in hepatocellular carcinoma.
Li JM; Zhou J; Xu Z; Huang HJ; Chen MJ; Ji JS
J Cell Biochem; 2018 Jul; 119(7):5143-5152. PubMed ID: 29143999
[TBL] [Abstract][Full Text] [Related]
13. miR-885-5p suppresses hepatocellular carcinoma metastasis and inhibits Wnt/β-catenin signaling pathway.
Zhang Z; Yin J; Yang J; Shen W; Zhang C; Mou W; Luo J; Yan H; Sun P; Luo Y; Tian Y; Xiang R
Oncotarget; 2016 Nov; 7(46):75038-75051. PubMed ID: 27738331
[TBL] [Abstract][Full Text] [Related]
14. Metallothionein 1H (MT1H) functions as a tumor suppressor in hepatocellular carcinoma through regulating Wnt/β-catenin signaling pathway.
Zheng Y; Jiang L; Hu Y; Xiao C; Xu N; Zhou J; Zhou X
BMC Cancer; 2017 Feb; 17(1):161. PubMed ID: 28241806
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma.
Huang JY; Zhang K; Chen DQ; Chen J; Feng B; Song H; Chen Y; Zhu Z; Lu L; De W; Wang R; Chen LB
Oncotarget; 2015 Jul; 6(21):18613-30. PubMed ID: 26164082
[TBL] [Abstract][Full Text] [Related]
16. Knockdown of miR-299-5p inhibits the progression of hepatocellular carcinoma by targeting SIAH1.
Jiang X; Shen X
Bull Cancer; 2018 Oct; 105(10):873-883. PubMed ID: 30266288
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-Mediated Regulation of HMGB1 in Human Hepatocellular Carcinoma.
Yan J; Ying S; Cai X
Biomed Res Int; 2018; 2018():2754941. PubMed ID: 29651425
[TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA AWPPH promotes hepatocellular carcinoma progression through YBX1 and serves as a prognostic biomarker.
Zhao X; Liu Y; Yu S
Biochim Biophys Acta Mol Basis Dis; 2017 Jul; 1863(7):1805-1816. PubMed ID: 28428004
[TBL] [Abstract][Full Text] [Related]
19. Glucose-regulated protein 94 mediates metastasis by CCT8 and the JNK pathway in hepatocellular carcinoma.
Wei PL; Huang CY; Tai CJ; Batzorig U; Cheng WL; Hunag MT; Chang YJ
Tumour Biol; 2016 Jun; 37(6):8219-27. PubMed ID: 26718209
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-552 promotes hepatocellular carcinoma progression by downregulating WIF1.
Li C; Wang Z; Chen S; Zhang J; Qu K; Liu C
Int J Mol Med; 2018 Dec; 42(6):3309-3317. PubMed ID: 30221686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
